• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

    9/27/23 11:10:24 AM ET
    $IRAA
    Blank Checks
    Finance
    Get the next $IRAA alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A Saba Capital Management, L.P.: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

    Iris Acquisition Corp

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

    89601Y101

    (CUSIP Number)

    September 26, 2023

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     [_]  Rule 13d-1(b)

     [  ]  Rule 13d-1(c)

     [X]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    SCHEDULE 13G/A

    CUSIP No.

    89601Y101


    1

    Names of Reporting Persons

    Saba Capital Management, L.P.

    2

    Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]

    3

    Sec Use Only

     

    4

    Citizenship or Place of Organization

    Delaware

    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With
    :

    5

    Sole Voting Power

    -0-

    6

    Shared Voting Power

    -0-

    7

    Sole Dispositive Power

    -0-

    8

    Shared Dispositive Power

    -0-

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-

    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]

    11

    Percent of class represented by amount in row (9)

    0%

    12

    Type of Reporting Person (See Instructions)

    PN; IA

           

    Page 2 of 7


    SCHEDULE 13G/A

    CUSIP No.

    89601Y101


    1

    Names of Reporting Persons

    Boaz R. Weinstein

    2

    Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]

    3

    Sec Use Only

     

    4

    Citizenship or Place of Organization

    United States

    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With
    :

    5

    Sole Voting Power

    -0-

    6

    Shared Voting Power

    -0-

    7

    Sole Dispositive Power

    -0-

    8

    Shared Dispositive Power

    -0-

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-

    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]

    11

    Percent of class represented by amount in row (9)

    0%

    12

    Type of Reporting Person (See Instructions)

    IN

           

    Page 3 of 7


    CUSIP No.

    89601Y101


    1

    Names of Reporting Persons

    Saba Capital Management GP, LLC

    2

    Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]

    3

    Sec Use Only

     

    4

    Citizenship or Place of Organization

    Delaware

    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With
    :

    5

    Sole Voting Power

    -0-

    6

    Shared Voting Power

    -0-

    7

    Sole Dispositive Power

    -0-

    8

    Shared Dispositive Power

    -0-

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-

    10

    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]

    11

    Percent of class represented by amount in row (9)

    0%

    12

    Type of Reporting Person (See Instructions)

    OO

           

    Page 4 of 7


    Item 1.

    (a) Name of Issuer: Iris Acquisition Corp

    (b) Address of Issuer's Principal Executive Offices: 3RD FLOOR ZEPHYR HOUSE, 122 MARY STREET, GEORGE TOWN, PO BOX 10085, GRAND CAYMAN, Cayman Islands, KY1-1001

    Item 2.

    (a) Name of Person Filing: Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"), Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"), and Mr. Boaz R. Weinstein (together, the "Reporting Persons").  The Reporting Persons have entered into a Joint Filing Agreement, dated February 23, 2023, pursuant to which the Reporting Persons have agreed to file this statement and any subsequent amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.  The filing of this statement should not be construed as an admission that any of the forgoing persons or the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.

    (b) Address of Principal Business Office or, if None, Residence:  The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.

    (c) Citizenship: Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.

    (d) Title and Class of Securities: Common stock, $0.0001 Par Value (the "Common Stock").

    (e) CUSIP No.: 89601Y101

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a) [_] Broker or dealer registered under Section 15 of the Act;

    (b) [_] Bank as defined in Section 3(a)(6) of the Act;

    (c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

    (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;

    (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

    (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

    (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

    Page 5 of 7


    (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

    (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4. Ownership

    (a) Amount Beneficially Owned: The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

    Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.  N/A

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A

    Item 8. Identification and classification of members of the group. N/A

    Item 9. Notice of Dissolution of Group.  N/A

    Item 10. Certifications.  N/A

    Page 6 of 7


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated:  September 27, 2023

    /s/ Signature  Michael D'Angelo

    Name: Michael D'Angelo

    Title: Chief Compliance Officer

    Boaz R. Weinstein

    By: Michael D'Angelo

    Title: Attorney-in-fact***

    *** Pursuant to a Power of Attorney dated as of November 16, 2015

    Page 7 of 7


    Get the next $IRAA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IRAA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IRAA
    SEC Filings

    View All

    SEC Form 15-12G filed by Iris Acquisition Corp

    15-12G - Iris Acquisition Corp (0001831874) (Filer)

    4/30/25 9:25:13 AM ET
    $IRAA
    Blank Checks
    Finance

    SEC Form 10-K filed by Iris Acquisition Corp

    10-K - Iris Acquisition Corp (0001831874) (Filer)

    4/15/25 9:48:28 PM ET
    $IRAA
    Blank Checks
    Finance

    SEC Form NT 10-K filed by Iris Acquisition Corp

    NT 10-K - Iris Acquisition Corp (0001831874) (Filer)

    3/31/25 4:01:42 PM ET
    $IRAA
    Blank Checks
    Finance

    $IRAA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Legion Partners Issues Letter to The Chefs' Warehouse, Inc. Shareholders Calling for Urgently Needed Board Change

    Highlights Company's Chronic Operational and Share Price Underperformance and the Need for New Skill Sets in the Boardroom to Help Chef Reach its Full Potential Nominates Four Highly Qualified, Independent Directors Who Would Bring Valuable Experience in Operations, Finance, Information Systems, Capital Allocation and Strategic Planning to the Board Legion Partners Asset Management, LLC, together with its affiliates (collectively, "we" or "Legion Partners"), is a significant shareholder of The Chefs' Warehouse, Inc. ("Chef", or the "Company") (NASDAQ:CHEF). Today, Legion Partners issued a public letter to the Company's shareholders announcing its nomination of four candidates to the Boa

    2/8/24 8:30:00 AM ET
    $AMPS
    $CHEF
    $F
    Electric Utilities: Central
    Utilities
    Food Distributors
    Consumer Discretionary

    Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

    NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") (NASDAQ:IRAA), a publicly traded special purpose acquisition company ("SPAC") formed for the purpose of acquiring or merging with one or more businesses, announced they have entered into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed "Liminatus Pharma, Inc.". The combined company's common stock is expected to be listed on the Nasdaq Capital Market. The transaction funding includes commitments for a $15

    12/5/22 7:00:00 AM ET
    $IRAA
    Blank Checks
    Finance

    Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments

    Businesses announce Definitive Business Combination Agreement and plan to operate under Liminatus Pharma The transaction values the combined companies at a pro forma enterprise value of $334 million The immune-modulating cancer treatments being developed by Liminatus are a GCC Vaccine, GCC CAR-T therapy and a CD47 immune checkpoint inhibitor. The GCC vaccine and CAR-T patent portfolio originated from Thomas Jefferson University (TJU). The CD47 checkpoint inhibitor originates from a South Korean biotech company InnoBation Bio Co. Ltd. The transaction is expected to be completed in the first half of 2023 Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company develo

    11/30/22 8:46:00 PM ET
    $IRAA
    Blank Checks
    Finance

    $IRAA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Saba Capital Management, L.P. sold $8,781,435 worth of shares (853,395 units at $10.29) (SEC Form 4)

    4 - Iris Acquisition Corp (0001831874) (Issuer)

    9/28/23 10:05:40 AM ET
    $IRAA
    Blank Checks
    Finance

    New insider Moore Capital Management, Lp claimed ownership of 100,000 shares (SEC Form 3)

    3 - Iris Acquisition Corp (0001831874) (Issuer)

    9/26/23 4:43:11 PM ET
    $IRAA
    Blank Checks
    Finance

    SEC Form 3: New insider Saba Capital Management, L.P. claimed ownership of 853,395 shares

    3 - Iris Acquisition Corp (0001831874) (Issuer)

    2/23/23 1:13:50 PM ET
    $IRAA
    Blank Checks
    Finance

    $IRAA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

    SC 13G/A - Iris Acquisition Corp (0001831874) (Subject)

    2/14/24 5:28:26 PM ET
    $IRAA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

    SC 13G/A - Iris Acquisition Corp (0001831874) (Subject)

    2/13/24 5:52:28 PM ET
    $IRAA
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Iris Acquisition Corp (Amendment)

    SC 13G/A - Iris Acquisition Corp (0001831874) (Subject)

    9/27/23 11:10:24 AM ET
    $IRAA
    Blank Checks
    Finance